The cobas® HPV test uncovers disease missed by cytology, providing more information about cancer risk in women with normal cytology (NILM) than pooled hrHPV testing alone.
Approximately one in 10 women with normal cytology who were HPV 16+ and/or 18+ actually had high-grade cervical disease that was missed with cytology.1
To learn more about the cobas® HPV test click here.
1. cobas® HPV Test [package insert, US].
Branchburg, NJ: Roche Molecular Systems, Inc; 2011.